The results obtained at the ELISA measurements proved that the Les-6287 compound can decrease the concentration of MMP-2, MMP-9, and ICAM-1 proteins involved in metastasis and poor prognosis in breast cancer patients (Figure 16). Here, ICAM1 is linked to breast carcinoma.